⭐ Recognized by FeedSpot: #12 Best Anesthesiology Blog Worldwide

Uncategorized Published - 20 December, 2016    By - Dr Clemens
Perioperative Management of Diabetes and the Emerging Role of Anaesthetists as Perioperative Physicians

Authors: N. Levy; N et al Br J Anaesth. 2016;116(4):443-447. Diabetes is the most common metabolic disorder and affects about 6–7% of the population and about 16% of the inpatient population.[1,2] Diabetes leads to accelerated atherosclerosis and patients are at higher risk of renal impairment, coronary vascular disease, peripheral vascular disease and cerebro-vascular disease. Subsequently, the surgical […]

Read More
Uncategorized Published - 20 December, 2016    By - Dr Clemens
Ambulatory Care Centers Need Perioperative Data

Anesthesiologists can take a few steps to improve the coordination of care throughout the perioperative period and should consider safety measures that will improve the preoperative process and postoperative outcomes. “Many of you probably say, ‘I do that already,’ but there are probably some aspects that you should consider that you probably aren’t doing,” said […]

Read More
Uncategorized Published - 20 December, 2016    By - Dr Clemens
Using SCOR To Improve the Quality of Your Anesthesia Practice

The Society for Ambulatory Anesthesia (SAMBA) Clinical Outcomes Registry (SCOR) may be a useful tool to help anesthesiologists improve the quality of their practices, preliminary data suggest. As the drive for quality continues, anesthesiologists must decide the best way to document and demonstrate quality measures. SCOR may be a good system for starting that process, […]

Read More
Uncategorized Published - 19 December, 2016    By - Dr Clemens
Vasopressin, Norepinephrine, and Vasodilatory Shock after Cardiac Surgery: Another “VASST” Difference?

Author: James A. Russell, A.B., M.D. Anesthesiology 1 2017, Vol.126, 9-11. HAJJAR et al designed, conducted, and now report in this issue an elegant randomized double-blind controlled trial of vasopressin (0.01 to 0.06 U/min) versus norepinephrine (10 to 60 μg/min) post cardiac surgery with vasodilatory shock (Vasopressin versusNorepinephrine in Patients with Vasoplegic Shock After Cardiac Surgery [VANCS] trial). Open-label norepinephrine was […]

Read More
Uncategorized Published - 19 December, 2016    By - Dr Clemens
Preoperative Administration of Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers: Do We Have Enough “VISION” to Stop It?

Author: Martin J. London, M.D. Anesthesiology 1 2017, Vol.126, 1-3. AS of 2012, angiotensin- converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) were used by approximately 18% of adults in the United States.1  In the Veterans Affairs medical system, a population with a high proportion of patients with cardiovascular disease and strong centralized efforts at […]

Read More